Emcure Pharmaceuticals Ltd.
EMCURE
Rank in Stocks
#4306
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Share Price
$19.06
Market Cap
$3.62B
Change (1 day)
-1.83%
Change (1 year)
20.50%
Country
IN
Trade Emcure Pharmaceuticals Ltd. (EMCURE)
Category
Healthcare
Stock split history for Emcure Pharmaceuticals Ltd. (EMCURE)
Emcure Pharmaceuticals Ltd. stock (symbol: EMCURE) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 22, 2026.
One EMCURE share bought prior to Oct 22, 2026 would equal to 0 EMCURE shares today.
The most recent stock split occurred on Oct 22, 2026.
One EMCURE share bought prior to Oct 22, 2026 would equal to 0 EMCURE shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
